Announcements

Nano Dimension Ltd. filed a Form 8-K on August 18, 2026, reporting the appointment of Nadav Kidron as a Class II director and disclosing the expiration of an exclusivity period with Infinite Epigenetics, Inc.

ASP Isotopes Inc. filed a Form 8-K on August 18, 2026, disclosing that its wholly-owned subsidiary, Quantum Leap Energy LLC, is evaluating metal conversion opportunities in Namibia.

Turn Therapeutics Inc. filed a Form 8-K on August 18, 2026, reporting that GEM Yield Bahamas Limited exercised a warrant in full on a cashless basis on August 13, 2026, resulting in the issuance of 579,664 shares of common stock.

Weave Communications, Inc. filed a current report on Form 8-K on August 18, 2026, disclosing the execution of an Agreement and Plan of Merger with Willow Parent, LLC and Willow Merger Sub, Inc., both affiliates of Francisco Partners Management, L.P.

Arxis, Inc. (NASDAQ:ARXS) filed a Form 8-K on August 18, 2026, disclosing the August 17, 2026, completion of its acquisition of Omnetics Connector Corporation through a merger agreement originally announced on May 29, 2026.

Dream Finders Homes, Inc. filed a Form 8-K on August 18, 2026, under Item 7.01 Regulation FD Disclosure, providing pro forma capitalization details expected immediately following its planned merger with Beazer Homes USA, Inc.

BioMarin Pharmaceutical Inc. filed a current report on Form 8-K on August 18, 2026, disclosing that it entered into a Share Purchase Agreement on August 17, 2026, to acquire Alesta Therapeutics B.V., a private Dutch rare disease company, for an upfront payment of $275 …